Aditya Birla Real Estate Limited (BOM:500040)
India · Delayed Price · Currency is INR 1,934.75
+41.65 (2.20%)
At close: Aug 4, 2025
Marinus Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 10,141 | 12,189 | 11,006 | 38,318 | 41,310 | 26,166 | Upgrade |
Other Revenue | 64.9 | 94.7 | 69.5 | 51.3 | 45.6 | 74.4 | Upgrade |
| 10,206 | 12,284 | 11,075 | 38,370 | 41,355 | 26,240 | Upgrade | |
Revenue Growth (YoY) | -78.63% | 10.91% | -71.14% | -7.22% | 57.60% | -23.45% | Upgrade |
Cost of Revenue | 6,158 | 7,495 | 5,299 | 21,067 | 24,874 | 14,827 | Upgrade |
Gross Profit | 4,048 | 4,788 | 5,776 | 17,303 | 16,481 | 11,413 | Upgrade |
Selling, General & Admin | 2,740 | 2,610 | 1,937 | 2,819 | 3,543 | 2,920 | Upgrade |
Other Operating Expenses | 1,772 | 1,788 | 1,343 | 8,745 | 8,448 | 6,182 | Upgrade |
Operating Expenses | 5,143 | 5,036 | 3,870 | 13,524 | 14,297 | 11,413 | Upgrade |
Operating Income | -1,096 | -247.3 | 1,906 | 3,779 | 2,184 | 0.1 | Upgrade |
Interest Expense | -316.2 | -355.6 | -199.4 | -245.2 | -430.2 | -612.5 | Upgrade |
Interest & Investment Income | 182.2 | 208.9 | 393.5 | 98.7 | 99.3 | 477.7 | Upgrade |
Earnings From Equity Investments | -80.8 | -135.3 | -224 | -18.4 | -1.3 | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | 4.8 | 70.9 | 25.8 | Upgrade |
Other Non Operating Income (Expenses) | -2.3 | -28 | -80.9 | -7 | 107.1 | -57.8 | Upgrade |
EBT Excluding Unusual Items | -1,313 | -557.3 | 1,796 | 3,612 | 2,030 | -166.7 | Upgrade |
Gain (Loss) on Sale of Assets | 7 | 7 | - | 1 | 16.1 | 1.6 | Upgrade |
Other Unusual Items | -1,240 | -1,240 | - | 1,342 | - | - | Upgrade |
Pretax Income | -2,545 | -1,790 | 1,796 | 4,955 | 2,046 | -165.1 | Upgrade |
Income Tax Expense | -485.3 | -302.6 | 513.1 | 1,729 | 504.4 | -14.4 | Upgrade |
Earnings From Continuing Operations | -2,060 | -1,487 | 1,283 | 3,226 | 1,542 | -150.7 | Upgrade |
Earnings From Discontinued Operations | 41.3 | -87 | -678.7 | -580.4 | 75.4 | -185.4 | Upgrade |
Net Income to Company | -2,019 | -1,574 | 603.8 | 2,646 | 1,617 | -336.1 | Upgrade |
Minority Interest in Earnings | 73.4 | -38.4 | -98.5 | 73.3 | 48.3 | 31.7 | Upgrade |
Net Income | -1,945 | -1,613 | 505.3 | 2,719 | 1,665 | -304.4 | Upgrade |
Net Income to Common | -1,945 | -1,613 | 505.3 | 2,719 | 1,665 | -304.4 | Upgrade |
Net Income Growth | - | - | -81.42% | 63.26% | - | - | Upgrade |
Shares Outstanding (Basic) | 110 | 110 | 111 | 112 | 112 | 112 | Upgrade |
Shares Outstanding (Diluted) | 110 | 110 | 111 | 112 | 112 | 112 | Upgrade |
Shares Change (YoY) | -0.51% | -0.37% | -0.70% | - | - | - | Upgrade |
EPS (Basic) | -17.62 | -14.60 | 4.57 | 24.34 | 14.91 | -2.73 | Upgrade |
EPS (Diluted) | -17.62 | -14.60 | 4.56 | 24.34 | 14.91 | -2.73 | Upgrade |
EPS Growth | - | - | -81.26% | 63.26% | - | - | Upgrade |
Free Cash Flow | - | -15,795 | -4,962 | 1,497 | -1,796 | 4,781 | Upgrade |
Free Cash Flow Per Share | - | -142.95 | -44.74 | 13.40 | -16.08 | 42.81 | Upgrade |
Dividend Per Share | - | 2.000 | 5.000 | 5.000 | 4.000 | 1.000 | Upgrade |
Dividend Growth | - | -60.00% | - | 25.00% | 300.00% | -66.67% | Upgrade |
Gross Margin | 39.66% | 38.98% | 52.16% | 45.09% | 39.85% | 43.50% | Upgrade |
Operating Margin | -10.73% | -2.01% | 17.21% | 9.85% | 5.28% | 0.00% | Upgrade |
Profit Margin | -19.06% | -13.13% | 4.56% | 7.09% | 4.03% | -1.16% | Upgrade |
Free Cash Flow Margin | - | -128.59% | -44.80% | 3.90% | -4.34% | 18.22% | Upgrade |
EBITDA | -813.95 | 388.1 | 3,957 | 5,990 | 4,433 | 2,256 | Upgrade |
EBITDA Margin | -7.98% | 3.16% | 35.73% | 15.61% | 10.72% | 8.60% | Upgrade |
D&A For EBITDA | 281.55 | 635.4 | 2,051 | 2,211 | 2,249 | 2,256 | Upgrade |
EBIT | -1,096 | -247.3 | 1,906 | 3,779 | 2,184 | 0.1 | Upgrade |
EBIT Margin | -10.73% | -2.01% | 17.21% | 9.85% | 5.28% | 0.00% | Upgrade |
Effective Tax Rate | - | - | 28.57% | 34.90% | 24.65% | - | Upgrade |
Revenue as Reported | 10,495 | 12,573 | 11,487 | 38,564 | 41,740 | 26,782 | Upgrade |
Advertising Expenses | - | 781.3 | 431 | 106 | 283.6 | 85.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.